Panacea Life Sciences Holdings, Inc.
PLSH· OTC
PLSHPanacea Life Sciences Holdings, Inc.
Filed Mar 29, 2019 · 10-K · 88 days after period end · 0001654954-19-003656
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $213.00 |
| Net Income | -$1.11M | -$2.04M | -$747.43K | -$68.91K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 29, 2019 · 88 d after period end
